Chronic Medical Conditions and CA125 Levels Among Women Without Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-18-0203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Predicting Circulating CA125 Levels Among Healthy Premenopausal Women

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Longitudinal Monitoring of CA125 Levels Provides Additional Information About Survival in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Epidemiology and Characteristics of Extra-Ovarian Conditions Mimicking Ovarian Cancer: A 4-Year Assay Among Iranian Women

International Journal of Travel Medicine and Global Health
2018English

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Polymorphisms in Cytokine Genes and Serum Cytokine Levels Among New Mexican Women With and Without Breast Cancer

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2010English

Use of a Symptom Index, CA125, and HE4 to Predict Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

Predictors of Pretreatment CA125 at Ovarian Cancer Diagnosis: A Pooled Analysis in the Ovarian Cancer Association Consortium

Cancer Causes and Control
Cancer ResearchOncology
2017English

The Efficacy of YKL-40 and CA125 as Biomarkers for Epithelial Ovarian Cancer

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2010English

Comorbid Depressive Symptoms and Chronic Medical Conditions Among US Chinese Older Adults

Journal of the American Geriatrics Society
GerontologyGeriatrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy